抗LAG3 [17B4] (Azide free)抗体 | Anti-LAG3 [17B4] (Azide free) antibody

• 特長
• 価格
• 製品情報
• APPLICATION
• PROPERTIES
• TARGET
• REFERENCEE(抜粋)

特長

• 高品質の抗体です。
• 幅広い研究分野に関連する抗体を取り揃えています。
• 使用されたアプリケーションや動物種などの情報が充実しています。
• 多数の論文で使用実績がある信頼性の高い抗体です。

目次に戻る

価格

目次に戻る

製品情報

Host	Mouse
Clonality	Monoclonal
Clone Name	17B4
Isotype	IgG1
Application	WB, ICC/IF, IHC-Fr, IP, Functional Assay
Reactivity	Human

目次に戻る

APPLICATION

Application Note

Functional Assay: Inhibition, Immunohistochemistry frozen sections: 1:150, Immunoprecipitation: 10μg/ml, Western Blot: 5μg/ml

Calculated MW	57 kDa. ( Note )
Specificity/Sensitivity	Recognizes human LAG-3.

目次に戻る

PROPERTIES

Form	Liquid
Buffer	PBS.
Storage	Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration	1 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species	Human
Immunogen	Synthetic peptide corresponding to 30 aa in the N-terminus of human LAG-3.
Purification	Protein A-affinity purified.
Conjugation	Unconjugated
Note	For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

目次に戻る

TARGET

Synonyms	Lymphocyte Activating 3 , Cd223 , Lag3
Background	Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4. [provided by RefSeq, Jul 2008]
Database	・ Gene ID: 3902 ・ UniProt: P18627

目次に戻る

REFERENCEE(抜粋)

Application Reference	Application/Reactivity
Casati C et al. J Immunol 2008; 180 (6):687601 Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation.
Triebel F et al. Cancer Lett 2006; 235 (1):147-53 A soluble lymphocyte activation gene-3 (sLAG-3) protein as a prognostic factor in human breast cancer expressing estrogen or progesterone receptors.
Di Carlo E et al. J Pathol 2005; 205 (1):82-91 Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway.
Macon-Lemaitre L et al. Immunology 2005; 115 (2):170-8 The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells.
Demeure CE et al. Eur J Cancer 2001; 37 (13):1709-18 T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.

目次に戻る